Skip to main content

Conference Coverage

ALN
January 07, 2021
In this Q&A, Dr Schairer answers our questions about the presentation, diagnosis, and treatment of dermatological conditions among patients with inflammatory bowel disease.
Rheumatology Consultant
December 07, 2020
In this video, Liana Fraenkel, MD, MPH, previews the recommendations that are included in the ACR guideline for the management of rheumatoid arthritis.
Rheumatology Consultant
November 13, 2020
While early diagnosis of psoriatic arthritis is key, a new study that was released during ACR Convergence shows that there is often a delay in diagnosis. Find out which patients are at the highest risk for delayed diagnosis.
Rheumatology Consultant
November 10, 2020
Patients with rheumatoid arthritis recently completed a survey about their experiences and satisfaction with their rheumatologist. The survey’s results were released during ACR Convergence.
Gastro Learning Network
October 27, 2020

Anne Griffiths, MD, of the Hospital for Sick Children in Toronto, spoke to the Advances in Inflammatory Bowel Diseases 2020 virtual meeting on research published this year into the special considerations involved in caring for children with Crohn disease and ulcerative colitis.

Gastro Learning Network
October 27, 2020

Clearly communicating the findings of endoscopy to pathologists, colleagues, and patients requires some standardization in the preparation of endoscopic reports, David T. Rubin, MD, told the attendees of the Advances in Inflammatory Bowel Diseases 2020 virtual meeting on December 11.

Gastro Learning Network
October 27, 2020

Updates to the SECURE-IBD international registry indicate that thiopurines and combination therapies may place patients with inflammatory bowel disease at heightened risk of poor outcomes from COVID-19, while anti-tumor necrosis factor agents may be protective.

Gastro Learning Network
October 27, 2020

Laurent Peyrin-Biroulet, MD, from the University of Nancy, France, spoke to the Advances in Inflammatory Bowel Diseases 2020 virtual meeting about surveillance, prevention, and treatment of cancer among patients with inflammatory bowel disease.

Gastro Learning Network
October 27, 2020

With many agents to choose from and even more slated for the near future, how do you choose the best therapy for your patients with inflammatory bowel disease? William Sandborn, MD, delved into the subject at the Advances in Inflammatory Bowel Diseases 2020 virtual meeting.

Gastro Learning Network
October 27, 2020

Aside from formal measurements of disease activity, there are still some practical approaches to assessing inflammatory bowel disease that can be helpful for clinicians, according to a presentation by Bruce Sands, MD, at the Advances in Inflammatory Bowel Disease 2020 virtual meeting.

Back to Top